BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang HY, Lu ZQ, Wang GX, Xie MR, Li CS. Presepsin as a biomarker for risk stratification for acute cholangitis in emergency department: A single-center study. World J Clin Cases 2021; 9(32): 9857-9868 [PMID: 34877324 DOI: 10.12998/wjcc.v9.i32.9857] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang F, Huang J, Yang J, Wang Y, Qiu B. Laparoscopic versus Conventional Surgery for Acute Cholangitis of Severe Type: A Systematic Review of Randomized Controlled Trials. Comput Math Methods Med 2022;2022:6828476. [PMID: 35756417 DOI: 10.1155/2022/6828476] [Reference Citation Analysis]
2 Deng X, Wang J, Wu Q, Pan L, Mou T, Du C. Lipocalin2 as a useful biomarker for risk stratification in patients with acute cholangitis: A single-center prospective and observational study. Clinica Chimica Acta 2022. [DOI: 10.1016/j.cca.2022.05.022] [Reference Citation Analysis]
3 Lee S, Lee T, Jeong J, Cheon Y. Clinical Significance of the Neutrophil–Lymphocyte Ratio as an Early Predictive Marker for Adverse Outcomes in Patients with Acute Cholangitis. Medicina 2022;58:255. [DOI: 10.3390/medicina58020255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]